Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 21;14(3):e0214160.
doi: 10.1371/journal.pone.0214160. eCollection 2019.

Potent inhibitors of equine steroid isomerase EcaGST A3-3

Affiliations

Potent inhibitors of equine steroid isomerase EcaGST A3-3

Helena Lindström et al. PLoS One. .

Abstract

Equine glutathione transferase A3-3 (EcaGST A3-3) belongs to the superfamily of detoxication enzymes found in all higher organisms. However, it is also the most efficient steroid double-bond isomerase known in mammals. Equus ferus caballus shares the steroidogenic pathway with Homo sapiens, which makes the horse a suitable animal model for investigations of human steroidogenesis. Inhibition of the enzyme has potential for treatment of steroid-hormone-dependent disorders. Screening of a library of FDA-approved drugs identified 16 out of 1040 compounds, which at 10 μM concentration afforded at least 50% inhibition of EcaGST A3-3. The most potent inhibitors, anthralin, sennoside A, tannic acid, and ethacrynic acid, were characterized by IC50 values in the submicromolar range when assayed with the natural substrate Δ5-androstene-3,17-dione.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The steroid double-bond isomerization reactions catalyzed by GST A3-3 with the substrates Δ5-androstene-3,17-dione and Δ5-pregnene-3,20-dione.
Fig 2
Fig 2. The most potent inhibitors (≥50% inhibition at 10 μM) from the US drug library screened with EcaGST A3-3.
Enzymatic activity was measured with 1 mM GSH and 1mM CDNB with and without 10 μM inhibitor in sodium phosphate buffer at pH 6.5 and 30°C.
Fig 3
Fig 3. Dose-response curves of potent inhibitors of EcaGST A3-3 tested with the alternative substrates CDNB and Δ5-AD.
Data points are means and standard deviations (SD) of triplicate measurements. The Hill coefficients represented by mean ± SD are for Δ5-AD inhibition: nanthralin = 1.9±0.19, nsennoside A = 2.1±0.29, ntannic acid = 2.1±0.63, nethacrynic acid = 1.0, and for CDNB inhibition: nanthralin = 2.0±0.43, nsennoside A = 2.2±0.41, ntannic acid = 2.2±0.23, nethacrynic acid = 2.5±0.21. The curve fitting for ethacrynic acid with androstenedione was not improved by using the Hill coefficient as a parameter and was therefore pre-set = 1.0 and presented no SD.
Fig 4
Fig 4
Substrate-saturation curves (A) and double reciprocal plot (B) of the most potent inhibitor anthralin with EcaGST A3-3 at varied concentrations of Δ5-AD. Data points are represented as means and standard deviations (SD) of triplicate measurements. The reaction was followed spectrophotometrically for 1 min at 1 mM GSH in the absence (blue) and presence (red) of 0.09 μM anthralin.

Similar articles

Cited by

References

    1. Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, et al. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev. 2006. December 1;58(4):782–97. 10.1124/pr.58.4.9 - DOI - PubMed
    1. Chatuphonprasert W, Jarukamjorn K, Ellinger I. Physiology and pathophysiology of steroid biosynthesis, transport and metabolism in the human placenta. Front Pharmacol. 2018;9:1027 10.3389/fphar.2018.01027 - DOI - PMC - PubMed
    1. Lee OD, Tillman K. An Overview of testosterone therapy. Am J Mens Health. 2016. January 1;10(1):68–72. 10.1177/1557988314556671 - DOI - PubMed
    1. Perrin JS, Hervé P-Y, Leonard G, Perron M, Pike GB, Pitiot A, et al. Growth of white matter in the adolescent brain: role of testosterone and androgen receptor. J Neurosci. 2008. September 17;28(38):9519–24. 10.1523/JNEUROSCI.1212-08.2008 - DOI - PMC - PubMed
    1. Reddy DS. Neurosteroids: endogenous role in the human brian and therapeutic potentials. Prog Brain Res. 2010;186:113–37. 10.1016/B978-0-444-53630-3.00008-7 - DOI - PMC - PubMed

Publication types

MeSH terms